STAT

‘I really love the feeling’: As vaping injuries climb, doctors struggle to wean youth off nicotine

With 12 deaths from vaping-related lung injuries confirmed, "kids are scared," but many don't know how to quit their nicotine addiction.

The 16-year-old looked sick. Tubes snaked around her face to deliver oxygen through her nose. Medication coursed into her veins through an IV. The culprit, her doctors said, was something in the e-cigarettes she used to inhale both nicotine and THC. Such reactions are rare though potentially serious: Of the 805 Americans reported to have this vaping-related lung injury, at least 12 have died.

But last week, when Dr. Melodi Pirzada, the chief pediatric pulmonologist at New York University’s Winthrop Hospital, on Long Island, told the teenager she needed to quit vaping, the response came as a surprise. “She was one of the patients who looked at me and said, ‘OK, the THC, that is fine, but the nicotine — I really love the feeling that I get with it. I don’t know if I’m ready to give that up,’” Pirzada recalled.

Her patient’s has grown, what had once seemed like a hazy possibility of negative health effects has become a lot more concrete. “Kids are scared,” said Meredith Berkman, one of the co-founders of . “This is the first time I’ve heard this from moms I’ve been speaking to for a while. Their kids never wanted to quit but now they do. I think we need to strike while the iron is hot.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks